{"database":"GEO","file_versions":[{"headers":{"Content-Type":["application/json"]},"body":{"files":{"Other":["ftp://ftp.ncbi.nlm.nih.gov/geo/series/GSE292nnn/GSE292752/"]},"type":"primary"},"statusCode":"OK","statusCodeValue":200}],"scores":null,"additional":{"omics_type":["Transcriptomics"],"species":["Mus musculus"],"gds_type":["Expression profiling by high throughput sequencing"],"full_dataset_link":["https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE292752"],"repository":["GEO"],"entry_type":["GSE"],"additional_accession":[]},"is_claimable":false,"name":"Targeting PACT to Broaden Antiviral Spectrum: The Role of Tubeimoside II in Modulating the RIG-I/MAVS/IRF-3 Signaling Pathway against Respiratory Viruses","description":"Traditional pharmacological experiments cannot detect the effects of respiratory viruses on lung cells, but viral infections can cause complex remodeling of different types. In this study, single-cell mRNA sequencing (scRNA seq) technology was used to identify key cell populations after influenza virus infection and TBM II administration, and to explore potential genetic changes that may occur in these cells.","dates":{"publication":"2026/05/27"},"accession":"GSE292752","cross_references":{"GSM":["GSM8864654","GSM8864655","GSM8864661","GSM8864662","GSM8864660","GSM8864658","GSM8864659","GSM8864656","GSM8864657"],"GPL":["24247"],"GSE":["292752"],"taxon":["Mus musculus"],"PMID":["[42180534]"]}}